×
About 25,085 results

ALLMedicine™ Constipation Center

Research & Reviews  5,506 results

Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotro...
https://doi.org/10.1002/14651858.CD006981.pub3
The Cochrane Database of Systematic Reviews; James E, Ellis C et. al.

May 21st, 2022 - Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative condition that may cause dysphagia, as well as limb weakness, dysarthria, emotional lability, and respiratory failure. Since normal s...

Effect of Probiotic on Constipation in Patients With Parkinson's Disease
https://clinicaltrials.gov/ct2/show/NCT04293159

May 20th, 2022 - The aim of the study is to collect data for the assessment of the Lactobacillus casei DG (Enterolactis® duo) effect on overall abdominal pain, bowel movements and other abdominal symptoms and on neuropsychological performance in patients with Park...

Laparoscopic Management of Spontaneous Colonic Perforation: A Single Institution Study ...
https://doi.org/10.1097/SLE.0000000000001057
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques; Li S, Zheng K et. al.

May 19th, 2022 - Spontaneous colonic perforation (SCP) is associated with an devastating result. The use of laparoscopy for SCP remains controversial. This study aimed to compare the postoperative outcomes of patients who received either laparoscopic or open surge...

The influence of Chinese herbal medicines on cancer-related pressure ulcer wound, fatig...
https://doi.org/10.1111/iwj.13833
International Wound Journal; Li H, Liu H

May 19th, 2022 - We performed a meta-analysis to evaluate the influence of Chinese herbal medicines on cancer-related pressure ulcer wounds, fatigue, constipation, and anorexia. A systematic literature search up to March 2022 was done and 25 studies included 1777 ...

Brazilian descriptive study of 104 consecutive real-world migraine patients treated wit...
https://doi.org/10.1080/00325481.2022.2080381
Postgraduate Medicine; Krymchantowski A, Silva-Néto RP et. al.

May 19th, 2022 - Migraine is a highly disabling and prevalent neurological disorder. A peptide, calcitonin gene-related peptide, was identified as involved in migraine pathophysiology and monoclonal anti-CGRP antibodies have been developed. To describe the clinica...

see more →

Guidelines  16 results

My Treatment Approach to Multiple System Atrophy.
https://doi.org/10.1016/j.mayocp.2020.10.005
Mayo Clinic Proceedings; Coon EA, Ahlskog JE

Mar 7th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a tertiary care center. The long-term manage...

European society of neurogastroenterology and motility guidelines on functional constip...
https://doi.org/10.1111/nmo.13762
Neurogastroenterology and Motility : the Official Journal... Serra J, Pohl D et. al.

Nov 23rd, 2019 - Chronic constipation is a common disorder with a reported prevalence ranging from 3% to 27% in the general population. Several management strategies, including diagnostic tests, empiric treatments, and specific treatments, have been developed. Our...

Medical Management of Opioid-Induced Constipation.
https://doi.org/10.1001/jama.2019.15852
JAMA Rao VL, Micic D et. al.

Nov 5th, 2019 - Medical Management of Opioid-Induced Constipation.|2019|Rao VL,Micic D,Davis AM,|adverse effects,therapeutic use,therapeutic use,therapeutic use,analogs & derivatives,therapeutic use,therapeutic use,drug therapy,therapeutic use,

MASCC recommendations on the management of constipation in patients with advanced cancer.
https://doi.org/10.1007/s00520-019-05016-4
Supportive Care in Cancer : Official Journal of the Multi... Davies A, Leach C et. al.

Aug 10th, 2019 - The Palliative Care Study Group of the Multinational Association for Supportive Care in Cancer formed a subgroup to develop evidence-based recommendations on the management of constipation in patients with advanced cancer. These recommendations we...

Opioid-Induced Constipation (OIC) Guideline.
https://doi.org/10.1053/j.gastro.2018.10.044
Gastroenterology Crockett S, Greer KB et. al.

Nov 6th, 2018 - Opioid-Induced Constipation (OIC) Guideline.|2018|Crockett S,Greer KB,Sultan S,|adverse effects,chemically induced,diagnosis,drug therapy,physiopathology,drug effects,standards,adverse effects,therapeutic use,adverse effects,therapeutic use,advers...

see more →

Drugs  2,611 results see all →

Clinicaltrials.gov  479 results

Effect of Probiotic on Constipation in Patients With Parkinson's Disease
https://clinicaltrials.gov/ct2/show/NCT04293159

May 20th, 2022 - The aim of the study is to collect data for the assessment of the Lactobacillus casei DG (Enterolactis® duo) effect on overall abdominal pain, bowel movements and other abdominal symptoms and on neuropsychological performance in patients with Park...

Safety and Efficacy Study of Endovenous Microwave Ablation for Treatment of Varicose Veins
https://clinicaltrials.gov/ct2/show/NCT04645771

May 16th, 2022 - The chronic venous insufficiency of lower extremities (chronic venous insufficiency, CVI) is a set of a series of clinical syndrome caused by venous reflux, common symptoms are heaviness, fatigue, swelling, burning sentation, itching, pain, etc.Th...

Cohort Study Assessing the Treatment Strategy for High-Risk Myelodysplastic Syndromes in Patients Under 70
https://clinicaltrials.gov/ct2/show/NCT05367583

May 10th, 2022 - Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders due to qualitative defects of the hematopoietic stem cell, resulting in uneffective hematopoiesis, dysplasia of one or more lineages, and subsequently, various cytopeni...

Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects .
https://clinicaltrials.gov/ct2/show/NCT05368116

May 10th, 2022 - Effectiveness A measure of the extent to which a specific intervention, procedure, regimen, or service when deployed in the field of routine circumstances, does it intended to do for a specific population. (Wojtezak, 2002) In this study, effective...

Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
https://clinicaltrials.gov/ct2/show/NCT02173405

May 10th, 2022 - BACKGROUND AND RATIONALE: Chronic pelvic pain affects 15-20% of the female population aged 18-50 years and accounts for up to 10% of gynecologic visits each year resulting in a cost of 2.8 billion dollars annually to the health care system. It is ...

see more →

News  1,258 results

Doctor Accused of 'Fraudulent Concealment' Can't Be Held Liable
https://www.medscape.com/viewarticle/974174

May 18th, 2022 - In April, the Iowa Supreme Court dismissed a knotty claim against a local doctor and hospital accused of concealing a woman's renal cancer, according to a story in the Iowa Capital Dispatch, among other news outlets. In 2004, Linda Berry visited M...

Do COVID Vaccines Stave Off New Medical Conditions?
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/98620

May 9th, 2022 - Risks of long COVID symptoms and the incidence of new onset hypertension, diabetes, and heart disease were lower among vaccinated patients with breakthrough infection versus those with COVID who were unvaccinated, a large analysis of medical recor...

FDA Issues Complete Response Letter to Toripalimab for Nasopharyngeal Carcinoma
https://www.onclive.com/view/fda-issues-complete-response-letter-to-toripalimab-for-nasopharyngeal-carcinoma

May 2nd, 2022 - The FDA has issued a complete response letter (CRL) to the biologics license application (BLA) seeking the approval of toripalimab for use in combination with gemcitabine and cisplatin in the frontline treatment of patients with advanced recurrent...

GIP/GLP-1 Receptor Agonist Slashes Body Weight by More Than 20%
https://www.medpagetoday.com/endocrinology/obesity/98512

May 2nd, 2022 - Tirzepatide, an investigational glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, helped people with overweight or obesity lose significant weight, Eli Lilly announced. In the 72-week, phase III SURMOUNT-1 clinical tri...

Ceralasertib Plus Acalabrutinib Shows Early Activity in High-Risk Relapsed/Refractory CLL
https://www.onclive.com/view/ceralasertib-plus-acalabrutinib-shows-early-activity-in-high-risk-relapsed-refractory-cll

Apr 29th, 2022 - The combination of ceralasertib (AZD6738) and acalabrutinib (Calquence) showed preliminary clinical activity with acceptable tolerability in patients with high-risk, relapsed/refractory chronic lymphocytic leukemia (CLL), according to data from a ...

see more →

Patient Education  164 results see all →